29 Mar 2024

Paragon 28 launches new solution for ankle ligament repair

Paragon 28 has launched the Grappler R3INFORCE Extraosseous Repair System, for enhancing the stability of the ankle's anterior and posterior ligaments during fibula fracture repairs and high ankle sprains. The…

28 Mar 2024

FDA clears Polymedco’s MI cardiac troponin test

Polymedco has received 510(k) clearance from the US Food and Drug Administration (FDA) for its rapid troponin assay as part of its Pathfast Biomarker Analyser. The troponin assay (hs-CTnl-II) detects…

28 Mar 2024

Novocure’s TTFields device slows metastasis in NSCLC

Novocure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression of brain metastasis in patients with non-small cell lung cancer…

28 Mar 2024

Nexalin’s device improves symptoms of mild traumatic brain injury

Nexalin Technology has revealed positive data from a clinical trial that evaluated its neurostimulation device in veteran patients with combat-related mild traumatic brain injury (mTBI). The randomised, double-blind, placebo-controlled trial…

28 Mar 2024

Elekta and MSD team up for digital kidney cancer care

Elekta has announced a collaboration with Merck & Co (MSD) to enhance care for individuals with advanced renal cell carcinoma (RCC) through the use of digital patient monitoring. This initiative…

28 Mar 2024

Medtronic swings FDA clearance for latest TAVR device

The US Food and Drug Administration (FDA) has granted approval to Medtronic the its Evolut FX+ transcatheter aortic valve replacement (TAVR) system. The device is designed for the treatment of…

[ajax_load_more post_type="post" taxonomy="category" taxonomy_terms="company-news, contract-news, deal-news, industry-news, news" taxonomy_operator="IN" images_loaded="true" posts_per_page="20" offset="7" pause="true" scroll="false" button_label="Load More Stories"]